The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index; none of the 162 sources its claims cite is checked for support yet.
Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline
Open accessAbstract
Objectives: To improve awareness and recognition of chronic bacterial prostatitis ( CBP ) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) among non‐specialists and patients. To provide guidance to healthcare professionals treating patients with CBP and CP / CPPS , in both non‐specialist and specialist settings. To promote efficient referral of care between non‐specialists and specialists and the involvement of the multidisciplinary team ( MDT ). Patients and Methods: The guideline population were men with CBP or CP / CPPS (persistent or recurrent symptoms and no other urogenital pathology for ≥3 of the previous 6 months). Consensus recommendations for the guidelines were based on a search to identify literature on the diagnosis and management of CBP and CP / CPPS (published between 1999 and February 2014). A Delphi panel process was used where high‐quality, published evidence was lacking. Results: CBP and CP / CPPS can present with a wide range of clinical manifestations. The four main symptom domains are urogenital pain, lower urinary tract symptoms ( LUTS – voiding or storage symptoms), psychological issues and sexual dysfunction. Patients should be managed according to their individual symptom pattern. Options for first‐line treatment include antibiotics, α‐adrenergic antagonists (if voiding LUTS are present) and simple analgesics. Repeated use of antibiotics, such as quinolones, should be avoided if there is no obvious symptomatic benefit from infection control or cultures do not support an infectious cause. Early use of treatments targeting neuropathic pain and/or referral to specialist services should be considered for patients who do not respond to initial measures. An MDT approach (urologists, pain specialists, nurse specialists, specialist physiotherapists, general practitioners, cognitive behavioural therapists/psychologists, and sexual health specialists) is recommended. Patients should be fully informed about the possible underlying causes and treatment options, including an explanation of the chronic pain cycle. Conclusion: Chronic prostatitis can present with a wide variety of signs and symptoms. Identification of individual symptom patterns and a symptom‐based treatment approach are recommended. Further research is required to evaluate management options for CBP and CP / CPPS .
Overview
CoChat Summary
TL;DR
This consensus guideline from the Prostatitis Expert Reference Group provides symptom-based diagnosis and management recommendations for chronic bacterial prostatitis (CBP) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). It recommends individualized care across four symptom domains, cautious antibiotic use, early consideration of neuropathic pain treatment/referral, and a multidisciplinary approach.
Key findings
- CBP and CP/CPPS should be managed by individual symptom pattern across four main domains: urogenital pain, lower urinary tract symptoms (LUTS), psychological issues, and sexual dysfunction; no single management pathway suits all patients.
- Reported symptom burdens include perineal pain as the most prevalent pain localization (63%), irritable bowel syndrome in 22–31%, ≥1 LUTS in 39–68%, and in CP/CPPS cohort studies (n = 130–1,800) total/partial erectile dysfunction in 15–55% and overall self-reported sexual dysfunction in 46–92%.
- First-line options include antibiotics, α-adrenergic antagonists if voiding LUTS are present, and simple analgesics; repeated quinolone use should be avoided if there is no obvious symptomatic benefit or cultures do not support infection, and early neuropathic pain treatment/referral plus multidisciplinary team care is recommended for non-responders.
- In CBP, microbiological eradication rates were 40–77% for ciprofloxacin, 75% for levofloxacin, 80% for azithromycin, 77% for doxycycline, 80% for clarithromycin, and 62–77% for azithromycin + ciprofloxacin; most α-blocker RCTs showed positive results, but two larger placebo-controlled trials of tamsulosin (n = 196) and alfuzosin (n = 272) failed to show significant total NIH-CPSI differences.
Methods
- Consensus guideline developed by the Prostatitis Expert Reference Group (PERG); guideline population were men with CBP or CP/CPPS, defined as persistent or recurrent symptoms and no other urogenital pathology for ≥3 of the previous 6 months.
- Literature search on diagnosis and management of CBP and CP/CPPS published between 1999 and 7 February 2014, primarily Medline via PubMed, plus Cochrane Library and guideline groups including NICE and EAU; references graded using Oxford Centre for Evidence-based Medicine Levels of Evidence.
- A web-based Delphi panel process was used where high-quality published evidence was lacking: three questionnaire rounds via Survey Monkey, circulated to 58 participants, with 35 (60%), 29 (50%), and 26 (45%) responding to rounds 1–3; consensus was defined as agreement of ≥70% of respondents, with PERG/technical input where consensus was not achieved.
Limitations
- Paper-stated: there are limited published randomised controlled trials in CBP and CP/CPPS; the Delphi panel was used where high-quality evidence was lacking; many recommendations are Level 5; further research is required; there is no “gold standard” for definitive CP/CPPS diagnosis; evidence is scarce for pain pharmacotherapy, surgical interventions, and CBT/psychotherapy; many studies are small, lack placebo/control arms, or are heterogeneous.
- Evident from the text: this is a consensus guideline rather than a systematic review or meta-analysis, and the Delphi panel had declining response rates (60% to 45%) with a ≥70% respondent consensus threshold, so several recommendations rest on expert opinion.
- Evident from the text: some cited evidence is indirect or limited, such as the REDUCE dutasteride study not being primarily designed as a CP/CPPS treatment trial, and several physiotherapy, acupuncture, phytotherapy, and surgical findings coming from small pilot or proof-of-principle studies.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
0 Valid · 0 Not valid · 89 Not checked · 29 Own results and interpretations
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The evidence on surgical management techniques such as prostatectomy, transurethral resection of the prostate (TURP), transrectal high‐intensity focused ultrasound (HIFU), transurethral needle ablation (TUNA) of the prostate, and transurethral microwave thermotherapy in CP/CPPS is very limited (Table 5).”
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Results > Recommendations (All Level 5)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“While it is recognised that psychosocial symptoms may be part of CBP and CP/CPPS 29, 41, 42, 43, no evidence from RCTs or comparative studies is available to support the use of psychological treatment or CBT in these settings.”
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Results > Recommendations (All Level 5)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Phytotherapy has a modest beneficial effect on symptom improvement in CBP and CP/CPPS and may be considered as a treatment option in treatment‐refractory patients (Level 2).”
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Results > Recommendations (All Level 5)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Several studies of acupuncture have provided positive results (Table 5).”
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Results > Recommendations (All Level 5)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Despite having a significant negative impact on patients' quality of life (QoL) 4 and presenting diagnostic and therapeutic challenges for physicians, CBP and CP/CPPS have received relatively little attention in the literature, in comparison with other urological conditions 2.”
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Introduction
What the sources say
- Not checked yetcites [2] Pavone‐Macaluso M. Chronic prostatitis syndrome: a common, but poorly understood condition. Part I. EAU‐EBU Update Ser 2007; 5: 1– 15
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
64 more claims
Create a free account to see all 118 claims and to verify the 128 references still open.
- Probably not a substantial claim. 15
- It may state two separate claims as one. 35
- The quote only partly states this claim. 2
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Results > Treatment Strategies
“Only two RCTs were identified for NSAIDs, one of which evaluated rofecoxib 75 (now withdrawn from the market). The second RCT evaluated celecoxib in patients with CP/CPPS”
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Results > Treatment Strategies
“An RCT (n = 50) evaluated ibuprofen vs a terpenic mixture (Rowatinex®) in CP/CPPS; ibuprofen (n = 25) was associated with a significant improvement from baseline in total, pain and QoL NIH‐CPSI scores after 6 weeks' treatment, but was outperformed by the terpene mixture 77.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Results > Treatment Strategies
“Most (eight) showed positive results, with significant differences vs placebo in NIH‐CPSI total, urinary symptom, pain, and/or QoL scores 54, 55, 56, 57, 59, 60, or in scores using other validated symptom scoring tools 58, 61.”
§ Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline > Results > Treatment Strategies
“Notably, two of the larger, placebo‐controlled trials that evaluated tamsulosin (n = 196) 53 and alfuzosin (n = 272) 57 failed to show any significant difference in total NIH‐CPSI scores, the only outcome achieving statistical significance being the score for ejaculation on the Male Sexual Health Questionnaire (P = 0.04) in the alfuzosin trial.”
Citations
Cites
The Delphi Technique: Making Sense of Consensus
Hsu, C.-C., & Sandford, B. A. (2007) · University of Massachusetts Amherst · doi:10.7275/pdz9-th90 · Cited by 4,500
LITWIN, M. S., McNAUGHTON-COLLINS, M., FOWLER, F. J., NICKEL, J. C., CALHOUN, E. A., PONTARI, M. A., ALEXANDER, R. B., FARRAR, J. T., & O'LEARY, M. P. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68562-x · Cited by 947
Guidelines on Urological Infections
Grabe, M. J., Bartoletti, R., Cai, T., Köves, B., Peter Tenke, A., Wagenlehner, F., & Wullt, B. (2009) · Cited by 759
Shoskes, D. A., Zeitlin, S. I., Shahed, A., & Rajfer, J. (1999) · Urology · doi:10.1016/s0090-4295(99)00358-1 · Cited by 408
Krieger, J. N., Lee, S. W. H., Jeon, J., Cheah, P. Y., Liong, M. L., & Riley, D. E. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.08.028 · Cited by 389
the Chronic Prostatitis Collaborative Research Network, McNaughton Collins, M., Pontari, M. A., O’Leary, M. P., Calhoun, E. A., Santanna, J., Landis, J. R., Kusek, J. W., & Litwin, M. S. (2001) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2001.01223.x · Cited by 281
Anothaisintawee, T. (2011) · JAMA · doi:10.1001/jama.2010.1913 · Cited by 278
Alexander, R. B., Propert, K. J., Schaeffer, A. J., Landis, J. R., Nickel, J. C., O'Leary, M. P., Pontari, M. A., McNaughton-Collins, M., Shoskes, D. A., Comiter, C. V., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-8-200410190-00005 · Cited by 262
ANDERSON, R. U., WISE, D., SAWYER, T., & CHAN, C. (2005) · Journal of Urology · doi:10.1097/01.ju.0000161609.31185.d5 · Cited by 210
Nickel, J. C., Downey, J., Clark, J. M., Casey, R. W., Pommerville, P. J., Barkin, J., Steinhoff, G., Brock, G. B., Patrick, A., Flax, S., et al. (2003) · Urology · doi:10.1016/s0090-4295(03)00583-1 · Cited by 206
Research works printed but not linked: 2
- Nyberg LM, 1999, Textbook of Prostatitis, 28
- University of Oxford Centre for Evidence Based Medicine.OCEBM Levels of Evidence System. Available at:http://www.cebm.net/index.aspx?o=5653. Accessed June 2014
Cited by
Items 301–369 of 369
Güncel Üroloji Çalışmaları VI - Prostat Hastalıkları
Karagöz, M. A., Akça, G., Uğurlu, M., Vural, F. A., Orman, E., Özcan, C., Dönmez, K., Yorulmaz, E. M., Kazaz, İ. O., Tepe, R. S., et al. (2025) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3445
IMMUNE STATUS OF PATIENTS WITH CHRONIC PROSTATITIS
Trishch, V. I., Mysak, A. I., & Trishch, A. (2025) · Ukrainian Journal of Urology · doi:10.71217/uju.1(5).2025.89-94
Rosellen, J., Fritzenwanker, M., Schuppe, H.-C., Schagdarsurengin, U., Wagenlehner, F., & Pilatz, A. M. E. (2025) · Diagnostics · doi:10.3390/diagnostics15081003
Dufour, S. P. (2025) · Physiotherapy Canada · doi:10.3138/ptc-2022-0071-cc
Az akut és krónikus prostatagyulladás ellátása, terápiás javaslatok
Takács, F. (2024) · Magyar urológia · doi:10.22591/magyurol.2024.2.takacsf.127
Palacio, E. V., Knape, P. B., Gabarró, S. T., Álvarez, C. C., Román, L. D. V., Sánchez-Puy, A., Castell, B. J., Solorzano, S. C., Burillo, E. S., pérez, L. M. M., et al. (2025) · Actas Urológicas Españolas · doi:10.1016/j.acuro.2025.501858
Alcohol promoted prostate microbial imbalance in the rat model of prostatitis
Zhu, X., Xu, P., He, Y., Lu, W., Wang, Z., & Liu, F. (2025) · American Journal of Translational Research · doi:10.62347/crgn1110
Palacio, E. V., Knape, P. B., Gabarró, S. T., Álvarez, C. C., Román, L. D. V., Sánchez-Puy, A., Castell, B. J., Solorzano, S. C., Burillo, E. S., pérez, L. M. M., et al. (2025) · Actas Urológicas Españolas (English Edition) · doi:10.1016/j.acuroe.2025.501858
Tay, C. L. (2025) · Springer eBooks · doi:10.1007/978-981-97-7640-5_125
Tay, C. L. (2025) · Springer eBooks · doi:10.1007/978-981-97-7640-5_127
Cyril, A. C., Lozon, Y., Jan, R. K., Shehab, S. A. S., Javed, H., Othman, M., Gaffari, Y. A., Karuvantevida, N. S., Kumar, J. S., Janahi, F. K., et al. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-02013-4
Trishch, V. I., & Mysak, A. I. (2025) · Ukrainian Journal of Urology · doi:10.71217/uju.4(8).2025.8-12
ACUTE PROSTATITIS, ETIOLOGY, RISK FACTORS AND STRATEGY OF TREATMENT
Yazeed Naif Almatrafi, A. F. A. (2019) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.3555437
Additional file 1 of The role of red ginseng in men’s reproductive health: a literature review
Wang, H., Zhang, J., Ma, D., Zhao, Z., Yan, B., & Wang, F. (2024) · Figshare · doi:10.6084/m9.figshare.26607697
Goluža, E., Hudolin, T., Konosić, S., Pranjić, M. N., Šprajc, S. N., Penezić, L., & Kuliš, T. (2024) · University of Zagreb University Computing Centre (SRCE) · doi:10.20471/acc.2024.63.s2.10
Dun, R.-L., Tsai, J., Hu, X.-H., Mao, J.-M., Zhu, W.-J., Qi, G.-C., & Peng, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14707816
Guan, X., Lao, Y., Wang, J., Wang, Y., Bai, Y., Li, X., Liu, S., Li, Z., Li, F., & Dong, Z. (2024) · Figshare · doi:10.6084/m9.figshare.26645365
Guan, X., Lao, Y., Wang, J., Wang, Y., Bai, Y., Li, X., Liu, S., Li, Z., Li, F., & Dong, Z. (2024) · Figshare · doi:10.6084/m9.figshare.26645395
Huang, N., Qin, Z., Sun, W., Bao, K., Zha, J., Zhang, P., panpan, F. P. F., Zhao, X., Liu, M., Shi, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24355105
Guan, X., Lao, Y., Wang, J., Wang, Y., Bai, Y., Li, X., Liu, S., Li, Z., Li, F., & Dong, Z. (2024) · Figshare · doi:10.6084/m9.figshare.26645398
Additional file 3 of The role of red ginseng in men’s reproductive health: a literature review
Wang, H., Zhang, J., Ma, D., Zhao, Z., Yan, B., & Wang, F. (2024) · Figshare · doi:10.6084/m9.figshare.26607703
Ye, Y., Zhong, W., Luo, R., Wen, H., Ma, Z., Qi, S., Han, X., Nie, W., Chang, D., Xu, R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25025914
Guan, X., Lao, Y., Wang, J., Wang, Y., Bai, Y., Li, X., Liu, S., Li, Z., Li, F., & Dong, Z. (2024) · Figshare · doi:10.6084/m9.figshare.26645404
Dun, R.-L., Tsai, J., Hu, X.-H., Mao, J.-M., Zhu, W.-J., Qi, G.-C., & Peng, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14707813
Huang, N., Qin, Z., Sun, W., Bao, K., Zha, J., Zhang, P., panpan, F. P. F., Zhao, X., Liu, M., Shi, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24355019
Modern possibilities for the treatment of chronic prostatitis
Fakhriddinovich, Y. I. (2024) · Центральноазиатский журнал образования и инноваций · doi:10.70413/cajei-v03-i05-s44947
Guan, X., Lao, Y., Wang, J., Wang, Y., Bai, Y., Li, X., Liu, S., Li, Z., Li, F., & Dong, Z. (2024) · Figshare · doi:10.6084/m9.figshare.24647300
Additional file 2 of The role of red ginseng in men’s reproductive health: a literature review
Wang, H., Zhang, J., Ma, D., Zhao, Z., Yan, B., & Wang, F. (2024) · Figshare · doi:10.6084/m9.figshare.26607700
Additional file 4 of The role of red ginseng in men’s reproductive health: a literature review
Wang, H., Zhang, J., Ma, D., Zhao, Z., Yan, B., & Wang, F. (2024) · Figshare · doi:10.6084/m9.figshare.26607706
Chen, J., Zhang, H., Niu, D., Li, H., Wei, K., Zhang, L., Yin, S., Liu, L., Zhang, X., Zhang, M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13065580
Guan, X., Lao, Y., Wang, J., Wang, Y., Bai, Y., Li, X., Liu, S., Li, Z., Li, F., & Dong, Z. (2024) · Figshare · doi:10.6084/m9.figshare.26645401
Guan, X., Lao, Y., Wang, J., Wang, Y., Bai, Y., Li, X., Liu, S., Li, Z., Li, F., & Dong, Z. (2023) · Figshare · doi:10.6084/m9.figshare.24647245
Vargas, L. R. (2023) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Relation between histological prostatitis and lower urinary tract symptoms and erectile function
水野, 太., & Mizuno, T. (2020)
PROSTATITIS, A NEUROMUSCULAR DISORDER: ITS CAUSES, SYMPTOMS, DIAGNOSIS, AND MANAGEMENT
Banerjee, K., Das, S., De, S., Pramanik, S., deshmukh, A. G., & Sarkar, D. R. (2024) · doi:10.58532/nbennurrapn11t1
Assessment of Ejaculate Parameters in Patients with Chronic Abacterial Prostatitis
Trishch, A., & Соломчак, Д. Б. (2025) · Health of Man · doi:10.30841/2786-7323.4.2025.350462
Зайцев, В. І., Stakhovskyi, O. E., & Липка, В. (2025) · Health of Man · doi:10.30841/2786-7323.4.2025.350452
Kasyan, G., Khodyreva, L., Grigoryan, B., & Дьяков, В. В. (2026) · Urologia Journal · doi:10.1177/03915603261421805
Chronic bacterial prostatitis. Literature review
Matulevičiūtė, A., Nikolaičiukaitė, S., & Želvytė, G. (2021) · Lithuanian University of Health Sciences
Extracorporeal Shock Wave Therapy for Chronic Prostatitis Treatment. Long-term Follow-up
Mickus, Ž. (2024) · Lithuanian University of Health Sciences
Effects of Nonhormonal Medical Treatment on Male Fertility
Calogero, A. E., Condorelli, R. A., Cannarella, R., & Vignera, S. L. (2026) · Endocrinology · doi:10.1007/978-3-319-29456-8_37-2
Comorbidités et syndromes de chevauchement dans la dyspepsie fonctionnelle
Wuestenberghs, F. (2023) · theses.fr (ABES) · doi:10.70675/09e7791ezf27az4f30z8b68z906f0ea311fa
Епифанова, М. В., Kostin, A. A., Slavkina, E. V., Artemenko, S., & Epifanov, А. А. (2026) · Andrology and Genital Surgery · doi:10.63769/2070-9781-2025-25-1-34-43
Kennedy, A. J., Weitzman, E., Um, J., Zwaans, B. M. M., & Peters, K. M. (2026) · International Urology and Nephrology · doi:10.1007/s11255-026-05189-y
Güncel Üroloji Çalışmaları IX: Sık Görülen Ürolojik Hastalıklar Tanı, İzlem ve Tedavi Yöntemleri
Yıldız, F., AYDIN, Y. M., Beyatlı, M., Şişik, N. M., Gelmiş, M., Gençtürk, Ö., Yurtseven, C. E., Duran, A. M., Bahçeci, T., Evci, M. U., et al. (2026) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.4122
Ghanim, A. F., Moschovas, M. C., Injiac, J., Chiriboga, A. S. S., Allegro, S., Rivera, T., & McDonald, M. (2026) · BMC Urology · doi:10.1186/s12894-026-02180-8
Guan, Y., Cheng, A., Chen, Y., Li, H., Yang, F. Y., Hao, W., Wang, Q., Liang, C. Y., & Meng, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1779951
Wei, X., Cui, J., Zang, Z., Pang, R., Qi, L., Wang, Y., Wang, H., Wu, Y., Qin, Z., & Wu, J. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-106160
Ren, H., Bai, W., Ye, G., Hong, N., Li, S., Zhang, K., Su, H., Luo, X., Liu, J., Yin, F., et al. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1765343
Primary investigation of negative impact on sexual function in patients with chronic prostatitis
Rosellen, J., Schuppe, H., Schagdarsurengin, U., Wagenlehner, F., & Pilatz, A. (2026) · Archivio Italiano di Urologia e Andrologia · doi:10.4081/aiua.2026.14810
ВПЛИВ ХРОНІЧНОГО АБАКТЕРІАЛЬНОГО ПРОСТАТИТУ НА БІОХІМІЧНІ ПАРАМЕТРИ ЕЯКУЛЯТУ
Trishch, A., & Соломчак, Д. Б. (2026) · Art of Medicine · doi:10.21802/artm.2026.2.38.75
Антонів, Р. Р., Мандзій, А. П., & Писар, А. М. (2026) · Art of Medicine · doi:10.21802/artm.2026.2.38.6
Rosellen, J., Pilatz, A., Schuppe, H., Schagdarsurengin, U., Hofmann, L., Deckmann, K., & Wagenlehner, F. (2026) · Urologia Internationalis · doi:10.1159/000553382
Опыт применения препарата Галавит в комплексном лечении хронического бактериального простатита
Панченко, И. А., & Panchenko, R. I. (2023) · Effective Pharmacotherapy
Bulus, B. P., Damare, A. A., & Buba, A. M. (2026) · International Journal of Research and Innovation in Applied Science · doi:10.51584/ijrias.2026.11060323
Hu, X., Gao, D., Tong, S., Zheng, X., & Sun, D. (2026) · American Journal of Men s Health · doi:10.1177/15579883261466474
Niu, D., Yue, S.-Y., Wang, X., Wei, S.-A., Li, W.-Y., Zhang, L., Du, H., & chao-zhao, L. (2026) · Asian Journal of Andrology · doi:10.4103/aja202587
Insights Into Infections and Inflammation in Prostate Cancer Development and Management: An Overview
Bahadoran, E., Babaei, A., Shahbazi, S., Badri, M., Nikkhahi, F., & Sabzi, S. (2026) · BioMed Research International · doi:10.1155/bmri/7584584
Prostatitis per enterococcus faecalis
Pérez, L., Marín, S., Delgado, J., Campins, L., & Miarons, M. (2019) · RACO (Revistes Catalanes amb Accés Obert) (Consorci de Serveis Universitaris de Catalunya)
Yang, Y., Peng, J., Zhang, X., Jiang, T., Zhang, N., & Jiang, H. (2026) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2026-0078
Chronic Prostatitis: Beyond the Triple A’s (Antibiotics, Anti-inflammatory, and Alpha-Blockers)
Atmoko, W., İvelik, H. İ., & Altay, B. (2026) · Springer eBooks · doi:10.1007/978-3-032-29112-7_26
Zhao, P., Li, W., Song, Y., Shen, B., He, Y., Jin, J., He, Z., & Gao, J. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117333
Effect of exercise intervention on chronic primary pelvic pain syndrome: A network meta-analysis
沈百林, Zhao, Z., Huang, W., & Wei, H. (2026) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2026.101179
Liu, X., Mo, J., Sun, Z., Liu, M., & Yang, Z. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1966858
Современные представления о хроническом воспалении простаты
Юрьевич, В. Ю., Kuzmenko, A. V., & Андреевич, А. А. (2022) · Urology reports (St - Petersburg)
A Scoping Review of Health Education Programs for Improving Men’s Engagement with Health Services
Hosseini, J., Gelehkolaee, K. S., Hajebrahimi, S., Shariatpanahi, S., Tahmasbi, F., Kabiri, N., Kantor, J., Mostafaei, H., Heidarzadeh, A., & Salehi‐Pourmehr, H. (2026) · Health Promotion Perspectives · doi:10.34172/hpp.45321
Shen, Y., & Ju, B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1955957
Zhang, A., Feng, R., Wu, B., & Cheng, Y. (2026) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2026.107073
Stevens, R. H., Zhang, H., Kajsik, M., Płoski, R., Rydzanicz, M., Sabaka, P., & Šutovský, S. (2023) · doi:10.3389/fmed.2023.1238147.s003
Metadata
- Authors
- Rees, J., Abrahams, M., Doble, A., Cooper, A., & the Prostatitis Expert Reference Group (PERG)
- Affiliations
- Backwell and Nailsea Medical Group Bristol UK
- Addenbrooke's Hospital (GB)
- Prostate Cancer UK (GB)
- Corresponding author
- Rees, Jon
- Venue
- BJU International
- Publisher
- Wiley
- Published
- 2015-06-16
- Volume
- 116
- Issue
- 4
- Pages
- 509-525
- ISSN
- 1464-4096 (ISSN-L)
- 1464-410X
- PMC
- PMC5008168
- OpenAlex
- W1997393900
- Semantic Scholar
- 09427e0cfa20489b48a373972c9f66172cfd9cf1
- Cited by
- 371
- References
- 113
- Citations by year
- 2026: 35 · 2025: 34 · 2024: 50 · 2023: 50 · 2022: 32 · 2021: 35 · 2020: 28 · 2019: 31 · 2018: 31 · 2017: 20 · 2016: 18 · 2015: 7
- FWCI
- 21.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- British Journal of Urology (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- Funders
- Prostate Cancer UK
- Topics
- Health Sciences › Medicine › Urology › Urinary Bladder and Prostate Research
- Health Sciences › Medicine › Urology › Urinary Tract Infections Management
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Keywords
- chronic bacterial prostatitis, chronic prostatitis/chronic pelvic pain syndrome, diagnosis, treatment, multidisciplinary team, lower urinary tract symptoms, urogenital pain, sexual dysfunction, neuropathic pain, alpha-blockers, antibiotics, quinolones, patient information, specialist referral
- MeSH terms
- Humans, Male, Prostatitis, Pelvic Pain, Consensus, Chronic Pain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.